相关实验视频

Updated: Jun 2, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

RSK1是骨髓增殖性新生体和二次急性髓性白血病中可利用的依赖性

Tim Kong¹, Angelo B A Laranjeira¹, Christopher T Letson¹

¹Division of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Nature communications

|January 17, 2025

概括

用抑制剂PMD-026向核糖体蛋白S6激酶A1 (RSK1) 有效地抑制了像骨髓扩散性瘤 (MPN) 和二次急性骨髓白血病 (sAML) 这样的骨髓性恶性瘤. 这种方法减少了炎症,并为这些血液癌症提供了新的治疗策略.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

骨髓质恶性瘤 (MPN,sAML) 是多种多样的,但具有共同的瘤信号通路和促炎环境.
了解这些共同的途径对于开发有效的治疗方法至关重要.

研究的目的:

创建一个全面的MPN和sAML的转录图谱.
为了确定这些骨髓瘤恶性瘤的关键信号通路和治疗点.
评估RSK1作为治疗策略的有效性.

主要方法:

158个初级MPN和sAML样本 (CD34+和CD14+细胞) 的RNA测序.
质量细胞计 (CyTOF) 用于蛋白质表达分析.
ATAC-Seq和CUT&Tag用于表观遗传分析.
在临床前白血病小鼠模型中评估RSK1抑制剂PMD-026.

主要成果:

鉴定出异常的PI3K/AKT/mTOR信号传递和NFκB介导的超级炎症.
证明RSK1抑制抑制NFκB激活和促炎介质 (例如TNF).
在多个MPN和sAML小鼠模型中,PMD-026治疗减少了疾病负担.

结论:

在MPN和sAML中,RSK1是一个关键的依赖.
用PMD-026准RSK1是一个有前途的治疗策略,用于骨髓瘤恶性瘤.
这项研究揭示了在MPN和sAML频谱中保留的漏洞.

更多相关视频

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

相关概念视频

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells: